This hypothesis could also explain the absence of TP53 point mutations, which are generally considered late events in colorectal carcinogenesis [65], and the relative scarcity of CTNNB1-activating point mutations in the incident CRC of our study, which were mostly of low stage. This evidence concerns the gene CTNNB1 and colorectal carcinoma.